Abstract Details

Title Intravenous Fibrinolysis 3 to 4.5 Hours after Acute Ischemic Stroke Onset: A Single Institution Experience

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 155

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Yazan Alderazi, MD, MB BCh BAO (HCA- Houston Healthcare)	No disclosure on file
Julian Yang, MD	No disclosure on file
Mohamed Teleb, MD (Banner Neuroscience)	Dr. Teleb has nothing to disclose.
	No disclosure on file
Heather Clark	The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care.
James L. Frey, MD, FAAN	No disclosure on file
Lucas Restrepo, MD, PhD (UCLA Medical Center)	Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file

��ɫ����